Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Clin Cancer Res. 2012 May 15;18(13):3677–3685. doi: 10.1158/1078-0432.CCR-11-3209

Table 1.

Changes in steroids from baseline to three months

SUB PATHWAY BIOCHEMICAL NAME Fold of change, Month 3 vs. Baseline p-value for paired t-test, Month 3 vs. Baseline q-value for paired t-test, Month 3 vs. Baseline
Sterol/Steroid cholesterol 1.06 0.029 0.120
dehydroisoandrosterone sulfate (DHEA-S) 0.87 < 0.001 0.002
epiandrosterone sulfate 0.50 < 0.001 <0.001
androsterone sulfate 0.50 < 0.001 <0.001
cortisol 0.84 0.012 0.072
cortisone 0.89 0.369 0.370
7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca) 1.01 0.653 0.478
4-androsten-3beta,17beta-diol disulfate 1 0.87 < 0.001 0.003
4-androsten-3beta,17beta-diol disulfate 2 0.70 < 0.001 <0.001
5alpha-androstan-3beta,17beta-diol disulfate 0.33 < 0.001 <0.001
pregnen-diol disulfate 0.76 < 0.001 <0.001
pregn steroid monosulfate 0.76 < 0.001 <0.001
andro steroid monosulfate 1 0.88 0.029 0.120
andro steroid monosulfate 2 0.93 0.321 0.356

• All values are normalized in terms of raw area counts.

• “Fold change Month 3 vs. Baseline” denotes <month 3 level> divided by <baseline level> of each biochemical (i.e. fold change of 0.76 denotes a 24% decrease).

• Shading corresponds to degree of change. Thresholds for color intensity are as follows: green denotes ≤ 0.65 fold change, dark green denotes 0.65 - 0.95 fold change, black denotes 0.95 – 1.05 fold change, dark red denotes 1.05 – 1.35 fold change, red denotes ≥ 1.35 fold change.